Cite
Immunotherapy with subcutaneous immunogenic autologous lysate against glioblastoma : Immunotherapie met subcutaan immunogeen autoloog tumor lysaat tegen glioblastomen
MLA
Belmans, J. Immunotherapy with Subcutaneous Immunogenic Autologous Lysate against Glioblastoma : Immunotherapie Met Subcutaan Immunogeen Autoloog Tumor Lysaat Tegen Glioblastomen. Oct. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1131..c339f217a72d504113f13fff51076bae&authtype=sso&custid=ns315887.
APA
Belmans, J. (2019). Immunotherapy with subcutaneous immunogenic autologous lysate against glioblastoma : Immunotherapie met subcutaan immunogeen autoloog tumor lysaat tegen glioblastomen.
Chicago
Belmans, J. 2019. “Immunotherapy with Subcutaneous Immunogenic Autologous Lysate against Glioblastoma : Immunotherapie Met Subcutaan Immunogeen Autoloog Tumor Lysaat Tegen Glioblastomen,” October. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......1131..c339f217a72d504113f13fff51076bae&authtype=sso&custid=ns315887.